$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch + Lomb beats Q4 profit and revenue estimates
07:14am, Wednesday, 22'nd Feb 2023
Bausch + Lomb Corp. BLCO, -2.01% said Wednesday it had a loss of $1 million, or breakeven on a per-share basis, for the fourth quarter, after earnings of $51 million, or 15 cents a share, in the year-
Bausch (BHC) Stock Jumps 19.3%: Will It Continue to Soar?
06:47am, Thursday, 16'th Feb 2023
Bausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Bausch + Lomb names ex-CEO Brent Saunders as CEO, replacing Joseph Papa
07:16am, Wednesday, 15'th Feb 2023
Bausch + Lomb Corp. BLCO, +1.31% said Wednesday it has named Brent Saunders as chief executive and chair effective March 6. Saunders, who will return to the company he headed from 2010 to 2013, will r
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
08:00am, Wednesday, 01'st Feb 2023
LAVAL, QC / ACCESSWIRE / February 1, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its fourth-quarter and full-year financial results on Thursday, Feb. 23, 2022. Bausch Health w
These Are The Top 10 Holdings Of John Paulson
10:54pm, Tuesday, 03'rd Jan 2023
John Paulson is the founder, president and portfolio manager at Paulson & Co.
Bausch Health: Things To Consider Before Investing
01:31am, Sunday, 11'th Dec 2022
Shares of Bausch Health are down over 70% this year. Underwhelming earnings and developments around the Xifaxan patent have been the primary drivers of underperformance vs. the broader equity market.
New Strong Sell Stocks for December 9th
01:23pm, Friday, 09'th Dec 2022 Zacks Investment Research
ACCO, BHC and HOUS have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2022.
New Strong Sell Stocks for December 9th
09:47am, Friday, 09'th Dec 2022
ACCO, BHC and HOUS have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2022.
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
06:33pm, Thursday, 01'st Dec 2022 Benzinga
Gainers
Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24.
Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
The Alkaline Water Company Inc. (NASDAQ: WTER) gained 37.5% to $0.24.
Wearab
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
04:13pm, Thursday, 01'st Dec 2022 Benzinga
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session.
Vaxxinity, Inc. (NASDAQ: VAXX) shares jumped 2
Bausch (BHC) Q3 Earnings & Sales Miss, Guidance Lowered
02:19pm, Friday, 04'th Nov 2022
Bausch (BHC) Q3 earnings and sales decline year over year due to the unfavorable impact of foreign exchange rates. The company also lowers its annual guidance.
Bausch Health Companies Inc. (BHC) Q3 2022 Earnings Call Transcript
11:39am, Thursday, 03'rd Nov 2022
Bausch Health Companies Inc. (NYSE:BHC ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Christina Cheng - Senior Vice President, Investor Relations and Communication
Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference
08:00am, Tuesday, 01'st Nov 2022
Nine Poster Presentations Include New Analyses of SILIQ ® and JUBLIA® LAVAL, QC / ACCESSWIRE / November 1, 2022 / - Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermato
Earnings Preview: Bausch Health (BHC) Q3 Earnings Expected to Decline
02:02pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tracking Carl Icahn's Portfolio - Q2 2022 Update
08:12am, Friday, 07'th Oct 2022 Seeking Alpha
Carl Icahn’s 13F portfolio value decreased from $21.87B to $20.86B this quarter. Click to see an update on Carl's holdings for Q2 2022.
Sign In
Buy BHC